ABL1 and chronic myelogenous leukemia, BCR-ABL1 positive: Previous reports indicate that SAHA downregulates BCR-ABL mRNA and protein levels in CML cells [13], which could be implicated in synergistic anti-leukemic interactions involving TKis [14].